Binimetinib Market Introduction
A small molecule inhibitor called binimetinib is used to treat cancer by blocking the activity of mitogen-activated protein kinase (MAPK) kinase (MEK). It is sold under the Mektovi brand. Binimetinib functions by preventing the MAPK signaling pathway's MEK1 and MEK2 proteins from acting. This pathway, which is frequently dysregulated in cancer cells, is...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian